Start Date: 2005
Financial penalties: none
End Date: still pending
This case mixes marketing and manufacturing violations.
The regulator cited the company for nonconformance with manufacturing regulations at a California facility that made over-the-counter eye drops. The FDA found also that two of the company's eye drop brands were unapproved, and that products had inadequate warning labels.